Back to Trades
Goldman Jonathan
DirectorCIK 0002013869
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025
Goldman Jonathan, Director, has filed 1 SEC report (2025), all concentrated in Avalo Therapeutics, Inc. (AVTX), totaling $325.0K in disclosed volume. Weighing $0 bought versus $162.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Nov 17 | AVTX Avalo Therapeutics, Inc. | Goldman Jonathan | Director | Sell | $162.9K |
1 filing